Mining imaging and clinical data with machine learning approaches for the diagnosis and early detection of Parkinson’s disease

被引:0
作者
Jing Zhang
机构
[1] Washington University in St. Louis,Department of Neurology, School of Medicine
来源
npj Parkinson's Disease | / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a common, progressive, and currently incurable neurodegenerative movement disorder. The diagnosis of PD is challenging, especially in the differential diagnosis of parkinsonism and in early PD detection. Due to the advantages of machine learning such as learning complex data patterns and making inferences for individuals, machine-learning techniques have been increasingly applied to the diagnosis of PD, and have shown some promising results. Machine-learning-based imaging applications have made it possible to help differentiate parkinsonism and detect PD at early stages automatically in a number of neuroimaging studies. Comparative studies have shown that machine-learning-based SPECT image analysis applications in PD have outperformed conventional semi-quantitative analysis in detecting PD-associated dopaminergic degeneration, performed comparably well as experts’ visual inspection, and helped improve PD diagnostic accuracy of radiologists. Using combined multi-modal (imaging and clinical) data in these applications may further enhance PD diagnosis and early detection. To integrate machine-learning-based diagnostic applications into clinical systems, further validation and optimization of these applications are needed to make them accurate and reliable. It is anticipated that machine-learning techniques will further help improve differential diagnosis of parkinsonism and early detection of PD, which may reduce the error rate of PD diagnosis and help detect PD at pre-motor stage to make it possible for early treatments (e.g., neuroprotective treatment) to slow down PD progression, prevent severe motor symptoms from emerging, and relieve patients from suffering.
引用
收藏
相关论文
共 185 条
[1]  
Rizzo G(2016)Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis Neurology 86 566-576
[2]  
Hughes AJ(2002)The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 125 861-870
[3]  
Daniel SE(2014)Low clinical diagnostic accuracy of early vs. advance Parkinson disease (Clinicopathologic study) Neurology 83 406-412
[4]  
Ben-Shlomo Y(2021)Clinical utility of DaTscan in patients with suspected Parkinsonia syndrome: a systematic review and meta-analysis NPJ Parkinson’s Dis. 7 43-635
[5]  
Lees AJ(2011)Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI) Prog. Neurobiol. 95 629-274
[6]  
Adler CH(2017)Imaging in Parkinson’s Disease Int Rev. Neurobiol. 132 233-2301
[7]  
Bega D(1991)Ageing and Parkinson’s disease: substantia nigra regional selectivity Brain 114 2283-810
[8]  
Marek M(2011)Age-specific progression of nigrostriatal dysfunction in Parkinson’s disease Ann. Neurol. 69 803-634
[9]  
Politis G(2016)Advances in markers of prodromal Parkinson disease Nat. Rev. Neurol. 12 622-259
[10]  
Pagano F(2007)A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry J. Neurol. Neurosurg. Psychiatry 78 254-3944